Company intelligence / Profile preview

SleepUp

Sao Caetano do Sul, São Paulo, Brazilen.sleepup.com.br ↗

Ownership: Private
Employees: ~30
Development stage: Commercial

Overview

SleepUp’s digital therapeutics platform has demonstrated significant improvements in insomnia severity index (-28%), increased total sleep time (+33 minutes/night), and reduced time to fall asleep (-55 minutes) in a study of over 1200 patients within one month. The solution is clinically validated and approved by ANVISA for the treatment of chronic insomnia.

Therapeutic areas: PulmonologyPsychiatryNeurology
Modalities: Non-pharmacological therapyDeviceMobile app/software as a medical device
Industry: Digital Health Medical Devices

Partnerships

Operates with retail pharmacy chains and health companies in Brazil.

Beyond the preview

Go deeper on SleepUp.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SleepUp.

Explore the full profile